Operating Lease, Right-of-Use Asset of Humacyte, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Humacyte, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Humacyte, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Humacyte, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q4 2024 $600,000 $0 0% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q4 2023 $600,000 -$100,000 -14% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q2 2023 $658,000 -$47,000 -6.7% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $670,000 -$46,000 -6.4% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $700,000 -$27,000 -3.7% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $693,000 -$45,000 -6.1% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $705,000 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $716,000 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $727,000 -$42,000 -5.5% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $738,000 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q4 2020 $769,000 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.